Ammonia → 2-(2-methoxyphenyl)-1-methyl-6-(methylthio)-1,2-dihydro-3H-pyrazolo[3,4-d]pyrimidin-3-one
反応式
[CH3:1][O:2][C:3]1[CH:8]=[CH:7][CH:6]=[CH:5][C:4]=1B(O)O.[CH3:12][N:13]1[C:17]2=[N:18][C:19]([S:22][CH3:23])=[N:20][CH:21]=[C:16]2[C:15](=[O:24])[NH:14]1.N.C(=O)([O-])O.[Na+]>C([O-])(=O)C.[Cu+2].C([O-])(=O)C.C(Cl)(Cl)Cl.CN(C)C=O.N1C=CC=CC=1>[CH3:1][O:2][C:3]1[CH:8]=[CH:7][CH:6]=[CH:5][C:4]=1[N:14]1[C:15](=[O:24])[C:16]2[C:17](=[N:18][C:19]([S:22][CH3:23])=[N:20][CH:21]=2)[N:13]1[CH3:12]参加物
8
反応物 4
生成物 1
試薬・触媒・溶媒 3
実験手順
280 mg of o-methoxyphenylboronic acid, 320 mg of copper(II) acetate and 0.15 mL of pyridine were added to a chloroform/N,N-dimethylformamide (1/1) solution of 90 mg of 1-methyl-6-(methylthio)-1,2-dihydro-3H-pyrazolo[3,4-d]pyrimidin-3-one, and stirred at room temperature. Aqueous 28% ammonia solution and saturated sodium hydrogencarbonate solution were added to the reaction liquid, and extracted with chloroform. The crude product was purified through a silica gel column (hexane/ethyl acetate) to obtain 68 mg of 2-(2-methoxyphenyl)-1-methyl-6-(methylthio)-1,2-dihydro-3H-pyrazolo[3,4-d]pyrimidin-3-one.
後処理
- extractionextracted with chloroform
- customThe crude product was purified through a silica gel column (hexane/ethyl acetate)
出典と根拠
- ORDレコード
- ord-49aeb71e3eb54298bea05ce6a875ed05
- 出典データセット
- uspto-grants-2010_11
- 特許番号
- US07834019B2
反応ノート
読み込み中…